Administrative Burden and Algorithmic Equity: A Randomized Trial of AI versus Human Assistance in Public Benefits Enrollment

Last registered on October 16, 2026

Pre-Trial

Trial Information

General Information

Title
Administrative Burden and Algorithmic Equity: A Randomized Trial of AI versus Human Assistance in Public Benefits Enrollment
RCT ID
AEARCTR-0019906
Initial registration date
October 07, 2026

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
October 16, 2026, 2:05 PM EDT

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Locations

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Primary Investigator

Affiliation
A Healthier Democracy

Other Primary Investigator(s)

Additional Trial Information

Status
In development
Start date
2026-12-01
End date
2028-07-31
Secondary IDs
Prior work
This trial does not extend or rely on any prior RCTs.
Abstract
Administrative burden depresses take-up of public benefits among eligible low-income households. This two-arm randomized controlled trial compares two modalities of remote enrollment assistance, an AI chatbot (LEO) versus a human patient navigator, delivered through Link Health's benefits-outreach channel at 6-10 community health centers in Massachusetts and Texas. Adults who click the study link in their health center's outreach text are randomized 1:1 server-side at the click, in permuted blocks within health-center-by-outreach-language strata. The primary outcome is verified approval of at least one benefit application (SNAP or Lifeline) within 60 days of randomization. The trial addresses the aggregate effect of assistance modality (RQ1), the behavioral mechanisms distinguishing the modalities (RQ2), and heterogeneity across subgroups defined by age, race/ethnicity, language, and household composition (RQ3). The design stands in equipoise: AI's structural advantages (availability, multilingual capacity, consistency) and navigators' relational advantages (trust, adaptive problem-solving) plausibly benefit different populations differently, and the hypotheses are bidirectional.
External Link(s)

Registration Citation

Citation
Lauterwasser, Steven. 2026. "Administrative Burden and Algorithmic Equity: A Randomized Trial of AI versus Human Assistance in Public Benefits Enrollment." AEA RCT Registry. October 16. https://doi.org/10.1257/rct.19906-1.0
Sponsors & Partners

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information
Experimental Details

Interventions

Intervention(s)
Both arms deliver the same service (eligibility screening, application completion, and submission for SNAP, Lifeline, and WIC through Link Health's standard pre-submission human review) through Link Health's remote benefits-assistance channel. Both arms are SMS conversations entered by a tap-to-text link carrying the assignment code. The AI arm is a conversation with LEO, Link Health's AI enrollment assistant, which identifies itself as automated, is continuously available in English and Spanish, and hands off to a human navigator on request, on fallback thresholds, and on distress flags. The human arm is a conversation with a trained Link Health remote navigator, staffed in shifts with response fulfillment targeted within 48 hours. The contrast is the modality of assistance as each is deployed, service levels included, with the channel held constant. Full description in the Analysis Plan §3.
Intervention Start Date
2026-12-01
Intervention End Date
2028-03-14

Primary Outcomes

Primary Outcomes (end points)
Verified approval of at least one benefit application submitted through Link Health (SNAP or Lifeline) within 60 days of randomization; the sole primary endpoint, tested without multiplicity adjustment. See Analysis Plan §6.
Primary Outcomes (explanation)

Secondary Outcomes

Secondary Outcomes (end points)
A confirmatory family of three, adjusted by Romano–Wolf stepdown: application submission within 90 days; completion of eligibility screening; exit at the opening block. Four further families, all exploratory and reported unadjusted with confidence intervals, are defined in Part B §6: exploratory enrollment outcomes (including per-program approval and submission for SNAP and Lifeline); component-capability measures (approval conditional on submission; review-stage correction rate; assistant-to-application fidelity); RQ2 process measures; and RQ3 heterogeneity.
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
Two-arm, individual-level randomized controlled trial delivered through Link Health's remote benefits-assistance channel. Each partner CHC texts its own patients, from its own platform, about free help enrolling in public benefits; the message carries a link coded to that health center and to the outreach language. Tapping the link is the single entry action: the study server logs the click, assigns the arm, and opens the participant's messaging app with a short text pre-filled, carrying the assignment code, addressed to the assigned arm's Link Health number; no page or form is shown and no phone number is entered. The mechanic is identical in both arms.

- **AI arm.** An SMS conversation with LEO, Link Health's AI enrollment assistant (inference on AWS Bedrock; SMS on Amazon SNS with AWS End User Messaging, in Link Health's AWS environment — a study build, since LEO's operational deployment is a web chat). LEO identifies itself as automated, delivers the research disclosure, screens for eligibility, completes applications conversationally, and submits through Link Health's standard human-review step. Participants may reach a human at any time on request; LEO also hands off on distress flags and fallback thresholds.
- **Human navigator arm.** An SMS conversation, on the same service, with a Link Health remote navigator, whose first message carries a one-line self-introduction and the same disclosure; the navigator screens, assists, and submits through the same review step.

**Service levels.** The AI arm is continuously available and responds immediately, in English and Spanish. The human arm is staffed by 5–20 trained navigators per campaign, shifts between 8am and 8pm Central, response fulfillment targeted within 48 hours of a wave — the service levels as currently staffed; the levels in force at launch are confirmed then and reported with the results. The asymmetry is part of the treatment as it exists: the estimand is the two modalities *as deployed*, service levels included, and response latency differs between arms by construction — an interpretive point for the process outcomes, not a limitation to adjust away. A participant who stalls or abandons mid-application receives, at minimum, follow-ups at approximately 48 hours and 7 days, in both arms, on an identical schedule, delivered channel-natively; the schedule is a floor — if Link Health's documented standard follow-up practice is denser, that practice becomes the floor, applied identically in both arms.

**What is and is not contrasted.** The arms differ in *who or what* provides the assistance and in nothing else the study controls: both are SMS conversations on Link Health's numbers, entered by the same tap-to-text mechanic, carrying the same four-message disclosure, with the same follow-up schedule and the same outcome contact. The estimand is AI assistance versus human assistance with the channel held constant — the modalities as deployed, service levels included. Both arms are new SMS deployments for the study (LEO's SMS delivery; the navigator pathway), which is what the QA wave exists to verify (§5).
Experimental Design Details
Not available
Randomization Method
Server-side assignment at the participant's entry tap, 1:1, by permuted blocks of randomly mixed sizes 4 and 6 within health-center × outreach-language strata, from pre-generated sequences held by the technical custodian; no human involvement in assignment; generation procedure and realized balance reviewed by Analyst Institute. See Analysis Plan §4.
Randomization Unit
Individual
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
4,300–7,000 randomized individuals, from a planned 6–10 CHCs sending roughly 90,000–150,000 messages; the registry record carries the planned range and is updated with the realized counts at closure. The denominator is everyone who clicks the study link, including those who leave immediately.
Sample size: planned number of observations
4,300–7,000 randomized individuals, from a planned 6–10 CHCs sending roughly 90,000–150,000 messages; the registry record carries the planned range and is updated with the realized counts at closure. The denominator is everyone who clicks the study link, including those who leave immediately.
Sample size (or number of clusters) by treatment arms
1:1 allocation — approximately 2,150–3,500 randomized individuals per arm over the planned range.
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
Two-sided α = 0.05, 80% power, over the randomized-N range 4,300–7,000. The ITT denominator is all clickers, while the ~40% operational enrollment baseline was measured among engaged applicants in the human-navigator channel, so the effective baseline is 40% × Pr(engage | click) and MDEs are registered across engagement scenarios: | Engagement rate | Effective baseline | MDE, main effect (ITT) | |---|---|---| | 30% | 12% | 2.2–2.8 pp | | 50% | 20% | 2.7–3.4 pp | | 70% | 28% | 3.0–3.8 pp | Subgroup MDEs scale with subgroup share: half the universe, 4.2–5.4 pp; one quarter, 6.0–7.7 pp; one tenth, 9.5–12.1 pp. The on-site LEO deployment's landing-page-to-conversation rate of ~27% is stated as a **floor** on the engagement rate; at that floor the effective baseline is ~11% and the main-effect MDE is approximately 2.2–2.8 pp, the same as the 30% row. See Analysis Plan §5.
IRB

Institutional Review Boards (IRBs)

IRB Name
IRB Approval Date
IRB Approval Number
Analysis Plan

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information